Sign in to view content

2 Real-World Analyses of Treatment Burden Associated With Intravitreal Injections for DME Prior to 0.2 mcg/Day Fluocinolone Acetonide (FAc)

Nancy M. Holekamp, MD, FASRS

Video
Published 2018

Related

Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew Starr, MD
Updates from the Field
2021
Pyron Award, “Treating AMD: Back to the Future”, Joan W. Miller, MD
Joan W. Miller, MD
Annual Meeting Talks
2018
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Caroline Baumal, MD
Updates from the Field
2021

Category: Diabetic Retinopathy

See more